Product Development

Alira Health Ventures: Incubation of Breakthrough Technologies

Developing tomorrow’s breakthroughs

As one of the few life science advisory firms with an in-house incubator dedicated to breakthrough technology, our commitment to transforming healthcare extends to our portfolio companies.

Alira Health Ventures manages these wholly-owned companies, providing critical support that allows them to develop the next technology breakthrough in Pharma and Life Sciences.

Delivering viable innovations to market

If you’re looking to expand your product portfolio, you can purchase or license our technologies that are designed to advance patient care—and your bottom line. Our discoveries deliver real value to patients, clinicians, and investors.

Accelerating Innovation, Transforming Healthcare

Alira Health Ventures offers support in product portfolio expansion, technology acquisition or licensing, and more.

Contact Us
Gabriele Brambilla
Gabriele Brambilla
Chief Executive Officer
Alira Health Ventures is dedicated to nurturing innovative technologies and propelling development from concept to clinical evaluation for future commercialization.

Related news

Research & Development
Publications June 9, 2021
EU Supply Integrity Guidelines
Check out Alira Health's latest publication, “EU Supply Integrity Guidelines”. In the document, best practices for European distribution and supply integrity management are highlighted(...)
Research & Development
Publications May 27, 2021
Buffers – Navigating New Demands On Downstream Raw Materials
The COVID-19 pandemic has put unusual pressures on the supply and demand of raw materials required for the production and purification of biologics. A specific concern for the biomanufacturing(...)
Research & Development
Publications April 26, 2021
Recombinant Human Polyclonal Antibodies to Treat Disease
Congratulations to Alira Health’s Steven Chamow, PhD, Senior Vice President, CMC and founder of Chamow & Associates, and to Bryan Monroe and Chuck Olson, Senior Consultants, on their(...)
Research & Development
News March 15, 2021
Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical
BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce that Nikole Siegmund has joined the firm(...)
Research & Development
Publications March 9, 2021
A Primer on Potency Assays for Release of Biologics
A key criterion in determining the quality of a biologic product is whether it has maintained its biological activity or “potency.”
Advanced Analytics Regulatory Research & Development
News November 20, 2020
Alira Health’s Ventures Portfolio Company, X-COR Therapeutics, Closes Initial $2.6M Funding Round
Alira Health congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials.(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.